Minapharm Pharmaceuticals (MIPH)

Currency in EGP
790.19
+27.36(+3.59%)
Closed·
Advertisement
MIPH is not included in our AI-picked strategies. See which stocks are.
Fair Value
Day's Range
745.00794.00
52 wk Range
232.01831.00
Key Statistics
Bid/Ask
753.01 / 792.00
Prev. Close
762.83
Open
761.09
Day's Range
745-794
52 wk Range
232.01-831
Volume
6.53K
Average Volume (3m)
4.77K
1-Year Change
217.3199%
Fair Value
unlockUnlock
Fair Value Upside
unlockUnlock
MIPH Scorecardpro icon
Company’s Health
Unlock
Fair Value
Unlock Price
Fair Price
Upside
Analysts Sentiment
Currently not supported.
Members' Sentiments
Bearish
Bullish
ProTips
Prominent player in the Pharmaceuticals industry

Technical Analysis

Summary
Strong Sell
Sell
Neutral
Buy
Strong Buy
Strong Buy
Technical Indicators
Strong Buy
Moving Averages
Strong Buy

Earnings

Latest Release
10/06/2026
EPS / Forecast
0.01 / --
Revenue / Forecast
1.6B / --
EPS Revisions
Last 90 days

Dividends

Payout Ratio
Payout ratio (TTM)
Earnings retained
EPS 28.52%
Dividend Yield
0.32%
Industry Median 1.60%
Annualised payout
2.50
Paid unevenly
5-Years Growth
-24.55%
Growth Streak

Compare MIPH to Peers and Sector

Metrics to compare
MIPH
Peers
Sector
Relationship
P/E Ratio
27.5x15.6x−0.3x
PEG Ratio
0.300.100.00
Price/Book
1.3x3.7x2.6x
Price / LTM Sales
1.4x2.8x3.1x
Upside (Analyst Target)
-21.5%48.5%
Fair Value Upside
Unlock−7.3%6.3%Unlock

MINAPHARM Pharmaceuticals produces medicines, chemicals, cosmetics, veterinary medical products, medical and dental supplies, nutritional supplements, and herbal medicines in Egypt and internationally. It operates through Bio-production, Drug production, and Other products. The company provides its products for the treatment of acne, alopecia, analgesics and anti-inflammation, atopic dermatitis, autoimmune disease, bone health, cardiovascular, cerebral insufficiency, diabetic neuropathy and retinopathy, dyslipidemia, gastroenterology and hepatology, glaucoma, hematoma and thrombosis, hemorrhoids, haemostasis, immuno-stimulants and immunomodulatory, and infertility, as well as for iron deficiency anemia, Ischemia, labour induction, menopause, nausea and vomiting, ocular infection and inflammation, osteoporosis, peripheral arterial, post operative management, pregnancy and lacation, probiotic and gut health, psoriasis, respiratory tract infection, rheumatoid arthritis, supplements, topical antibiotics, topical muscle relaxant, and venous disease. MINAPHARM Pharmaceuticals was founded in 1958 and is headquartered in Cairo, Egypt.

Market
Egypt

Ownership

Ownership Overview

Type
Common Stock Held% of Shares OutstandingMarket Value
Mutual Funds & ETFs
0.000.00%0.00
Other Institutional Investors
9.78M83.05%7.46B
Public Companies & Retail Investors
2.00M16.95%1.52B
Total
11.78M100.00%8.99B

Top Holders

Holder
% of holding
Shares Held
Date Reported
Value (In 1,000s)
Show Canada Industries, Inc.83.05%9,784,6457,464,021

People Also Watch

332.00
NIPH
-2.36%
104.00
ACRO
0.00%
620.16
SCTS
-0.26%
21.71
NINH
-0.91%

FAQ

What Is the Minapharm Pharma (Egypt: MIPH) Share Price Today?

The Minapharm Pharma stock price today is 790.19 EGP.

What Stock Exchange Does Minapharm Pharma (MIPH) Trade On?

Minapharm Pharma is listed and trades on the Egypt Stock Exchange.

What Is the Ticker (Stock Symbol) for Minapharm Pharma?

The stock symbol (also called a 'ticker') for Minapharm Pharma is "MIPH."

Does Minapharm Pharma Pay Dividends? What’s The Current MIPH Dividend Yield?

Yes, MIPH Pays Dividends to its Shareholders. The current Minapharm Pharma dividend yield is 0.32%.

What Is the Current Minapharm Pharma Market Capitalisation?

As of today, Minapharm Pharma (Egypt: MIPH) market cap is 9.31B EGP.

What Is Minapharm Pharma's (MIPH) Earnings Per Share (TTM)?

The Minapharm Pharma EPS is currently 28.52 (Trailing Twelve Months).

Is MIPH a Buy or Sell From a Technical Analyst Perspective?

Based on today's Minapharm Pharma moving averages and other technical indicators, the daily buy/sell signal for MIPH stock is Strong Buy.

How Many Times Has Minapharm Pharma Stock Split?

Minapharm Pharma has split 3 times. (See the MIPH stock split history page for full effective split date and price information.)

What is the current trading status of Minapharm Pharma (Egypt: MIPH)?

As of 21/08/2026, Minapharm Pharma (MIPH) is trading at a share price of 790.19 EGP, with a previous close of 762.83 EGP. The stock has fluctuated within a day range of 745.00 EGP to 794.00 EGP, while its 52-week range spans from 232.01 EGP to 831.00 EGP.
Risk Disclosure: Trading in financial instruments and/or cryptocurrencies involves high risks including the risk of losing some, or all, of your investment amount, and may not be suitable for all investors. Prices of cryptocurrencies are extremely volatile and may be affected by external factors such as financial, regulatory or political events. Trading on margin increases the financial risks.
Before deciding to trade in financial instrument or cryptocurrencies you should be fully informed of the risks and costs associated with trading the financial markets, carefully consider your investment objectives, level of experience, and risk appetite, and seek professional advice where needed.
Fusion Media would like to remind you that the data contained in this website is not necessarily real-time nor accurate. The data and prices on the website are not necessarily provided by any market or exchange, but may be provided by market makers, and so prices may not be accurate and may differ from the actual price at any given market, meaning prices are indicative and not appropriate for trading purposes. Fusion Media and any provider of the data contained in this website will not accept liability for any loss or damage as a result of your trading, or your reliance on the information contained within this website.
It is prohibited to use, store, reproduce, display, modify, transmit or distribute the data contained in this website without the explicit prior written permission of Fusion Media and/or the data provider. All intellectual property rights are reserved by the providers and/or the exchange providing the data contained in this website.
Fusion Media may be compensated by the advertisers that appear on the website, based on your interaction with the advertisements or advertisers.
© 2007-2026 - Fusion Media Limited. All Rights Reserved.